Similarly, the trypan blue staining assay results also supported that hsa_circRNA_103809 overexpression rescued cell viability in CS-NSCLC cells under cisplatin treatment by sponging miR-337-3p and upregulating GOT1 (Fold changes: Cis + OE-circ+OE-miR and Cis + OE-circ+KD-GOT1 vs. Cis + OE-circ, 0.63 and 0.54 in A549; 0.54 and 0.61 in H1299; 0.32 and 0.28 in Calu-3. The gene discussed is GOT1; the disease is non-small cell lung carcinoma.